ライフサイエンスコーパス: interleukin-1 receptor-associated kinase

1 of the LPS signaling pathway at the level of interleukin-1 receptor-associated kinase.

2 of EGFR and the NF-kappaB regulatory kinase interleukin 1 receptor-associated kinase 1 (IRAK-1).

3 This included a Phe196Ser change in the interleukin 1 receptor-associated kinase 1 (IRAK1).

4 Interleukin 1 receptor-associated kinase 1(IRAK1), a key

5 We also demonstrate that MyD88, interleukin 1 receptor-associated kinase 1, and tumor ne

6 s study, we examined the contribution of the interleukin-1 receptor-associated kinase 1 (IRAK-1) to L

7 id differentiation primary response (MyD88), interleukin-1 receptor-associated kinase 1 (IRAK-1), and

8 ion with NF-kappaB-inducing kinase (NIK) and interleukin-1 receptor-associated kinase 1 (IRAK-1), deg

9 Here we report that interleukin-1 receptor-associated kinase 1 (IRAK1) is ov

10 Inhibition of BTK or interleukin-1 receptor-associated kinase 1 and 4 (IRAK-1

11 use of TMP with Bruton's tyrosine kinase or interleukin-1 receptor-associated kinase 1 and 4 inhibit

12 74 x 10(-6)) and a C203S polymorphism in the interleukin-1 receptor-associated kinase 1 gene (IRAK1)

13 rvival pathway, leading to downregulation of interleukin-1 receptor-associated kinase 1.

14 Blocking NF-kappaB signals by inhibitors of interleukin-1 receptor-associated kinase 1/4 (IRAK1/4 in

15 wed for an improvement of selectivity versus interleukin-1 receptor-associated kinases 1 and 4 (IRAK1

16 main containing adaptor protein)-MyD88-IRAK (interleukin-1 receptor-associated kinase)1/4-TRAF6 (TNF

17 s undertaken to test the candidacy of IRAK1 (interleukin-1 receptor associated kinase-1) as an X chro

18 Interleukin-1 receptor-associated kinase-1 (IRAK-1) and

19 cts, we have identified a role for MyD88 and interleukin-1 receptor-associated kinase-1 (IRAK-1) in m

20 o-1 actions were likely to be independent of interleukin-1 receptor-associated kinase-1 (IRAK-1) regu

21 miRNA-146a down-regulates expression of the interleukin-1 receptor-associated kinase-1 (IRAK-1), an

22 h diminished IL-1beta-induced degradation of interleukin-1 receptor-associated kinase-1 (IRAK-1).

23 gulating Lys-63-linked polyubiquitination of interleukin-1 receptor-associated kinase-1 (IRAK1) by th

24 We report that B. vulgatus induced interleukin-1 receptor-associated kinase-1 degradation,

25 pression, myeloid differentiation factor 88, interleukin-1 receptor-associated kinase-1, and nuclear

26 ed NFkappaB activation, via interaction with interleukin-1 receptor-associated kinase 2 (IRAK2).

27 8), which lead to constitutive activation of interleukin-1 receptor associated kinase 4 (IRAK4) and c

28 Interleukin-1 receptor associated kinase 4 (IRAK4) is an

29 a series of pyrrolopyrimidine inhibitors of interleukin-1 receptor associated kinase 4 (IRAK4) using

30 B cells isolated from patients deficient for interleukin-1 receptor-associated kinase 4 (IRAK-4), mye

31 onse was reversed in the patient, but not in interleukin-1 receptor-associated kinase 4 (IRAK-4)-defi

32 Interleukin-1 receptor-associated kinase 4 (IRAK4) activ

33 Interleukin-1 receptor-associated kinase 4 (IRAK4) is a

34 Interleukin-1 receptor-associated kinase 4 (IRAK4) is a

35 samples was analyzed and functional roles of interleukin-1 receptor-associated kinase 4 (IRAK4) isofo

36 1 receptor signal transduction by inhibiting interleukin-1 receptor-associated kinase 4 (IRAK4) offer

37 Interleukin-1 receptor-associated kinase 4 (IRAK4) plays

38 Interleukin-1 receptor-associated kinase 4 (IRAK4) plays

39 Interleukin-1 receptor-associated kinase 4 (IRAK4) was t

40 Finally, pharmacological targeting of interleukin-1 receptor-associated kinase 4 (IRAK4) with

41 ying very rare loss-of-function mutations in interleukin-1 receptor-associated kinase 4 (IRAK4), a cr

42 Interleukin-1 receptor-associated kinase 4 (IRAK4), a ma

43 diminished degradation and interaction with interleukin-1 receptor-associated kinase 4 (IRAK4).

44 he Toll-like receptor (TLR) pathway, such as interleukin-1 receptor-associated kinase 4 deficiency, h

45 vival and stromal fibrosis, and is driven by Interleukin-1 Receptor Associated Kinase-4 (IRAK4), but

46 Interleukin-1 receptor-associated kinase-4 (IRAK-4) is a

47 iation factor 88-dependent signaling through interleukin-1 receptor-associated kinase-4 and p38 leadi

48 l as GD1a itself inhibited flagellin-induced interleukin-1 receptor-associated kinase activation as w

49 nitude of flagellin signaling as measured by interleukin-1 receptor-associated kinase activation or t

50 rotic genes, no correlation was observed for interleukin-1 receptor-associated kinase and colony-stim

51 ression induced by CpG DNA, and suggest that interleukin-1 receptor-associated kinase and/or TRAF6 ma

52 had impaired S aureus-induced activation of interleukin-1 receptor-associated kinase, c-Jun NH2 term

53 regulation of 2 inhibitors of TLR signaling: Interleukin 1 Receptor Associated Kinase (IRAK) M, and S

54 canonical downstream signaling intermediates interleukin 1 receptor-associated kinase (IRAK) and Ikap

55 demonstrate an NGF-dependent association of interleukin 1 receptor-associated kinase (IRAK) with the

56 n primary murine macrophages, dependent upon interleukin 1 receptor-associated kinase (IRAK-1).

57 In particular, a family of four interleukin 1 receptor-associated kinases (IRAK) regulat

58 differentiation primary response 88 (MYD88)/interleukin-1 receptor associated kinase (IRAK) pathway,

59 tate level of toll-like receptor 5 (TLR5) or interleukin-1 receptor associated kinase (IRAK), but it

60 88 L265P mutant results in the activation of interleukin-1 receptor associated kinase (IRAK).

61 gh tyrosine nitration-mediated impairment of interleukin-1 receptor associated kinase (IRAK)4, a sign

62 Interleukin-1 receptor-associated kinase (IRAK) -1 plays

63 e residues in the known TLR pathway kinases, Interleukin-1 receptor-associated kinase (IRAK) 2 and IR

64 pathway involving the MyD88 adapter and the interleukin-1 receptor-associated kinase (IRAK) complex.

65 IRAK2, a member of the interleukin-1 receptor-associated kinase (IRAK) family,

66 nes encoding non-RD kinases belonging to the interleukin-1 receptor-associated kinase (IRAK) family.

67 L-1) stimulation leads to the recruitment of interleukin-1 receptor-associated kinase (IRAK) to the I

68 -1 stimulation, the majority of the cellular interleukin-1 receptor-associated kinase (IRAK) transloc

69 The interleukin-1 receptor-associated kinase (IRAK) was firs

70 Interleukin-1 receptor-associated kinase (IRAK), a signa

71 pretreatment in vivo inhibited expression of interleukin-1 receptor-associated kinase (IRAK)-1 while

72 , antisense JNK and dominant negative MyD88, interleukin-1 receptor-associated kinase (IRAK)-1, IRAK4

73 le, a Drosophila homolog of the human kinase interleukin-1 receptor-associated kinase (IRAK).

74 Here, we show that the interleukin-1 receptor-associated kinase (IRAK)/Pelle-li

75 receptor-4 (TLR4) and its signaling molecule interleukin-1 receptor-associated kinase (IRAK-1) play a

76 R4-mediated signaling pathway (reduced MyD88-interleukin-1 receptor-associated kinase [IRAK] interact

77 mammals and overlaps with the 5' UTR of the interleukin 1 receptor-associated kinase (IRAK1) gene.

78 Within innate immune signaling pathways, interleukin-1 receptor-associated kinases (IRAKs) fulfil

79 its DD and TIR domain and interacts with the interleukin-1 receptor-associated kinases (IRAKs) to for

80 mber 6, and rhophilin 2) and three proteins (interleukin 1 receptor-associated kinase-like 2, glutama

81 Here, we identified interleukin-1 receptor-associated kinase M (IRAK-M) as a

82 y factor-1, tumor necrosis factor-alpha, and interleukin-1 receptor-associated kinase-M mRNA in human

83 ly member, the mouse Pelle-like kinase/human interleukin-1 receptor-associated kinase (mPLK/IRAK), ha

84 Abs induced activation of TLR4 and triggered interleukin-1 receptor-associated kinase phosphorylation